Stock Events

Stock Events

China SXT Pharmaceuticals 

$3.00
50
-$0.46-13.29% Friday 20:00
+$0.08+2.67%Friday 23:52After hours

Statistics

Day High
3.02
Day Low
3.02
52W High
300
52W Low
0.046
Volume
2,228
Avg. Volume
-
Mkt Cap
1.6M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

18JulExpected
Q3 2019
Q1 2020
Q2 2020
Q4 2020
Q2 2021
Q4 2021
Q2 2022
-2.03
-1.32
-0.61
0.1
Expected EPS
0
Actual EPS
-2.03

Financials

-545.25%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.14MRevenue
-6.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SXTC. It's not an investment recommendation.
Realty Income
8
O
NVIDIA
8
NVDA
AGNC Investment
7
AGNC
Pfizer
7
PFE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
111
YI
Mkt Cap31.41M
111, Inc. operates a leading direct-to-patient digital healthcare platform in China, offering similar pharmaceutical products and services, thus competing in the same market space.
Zai Lab Limited
ZLAB
Mkt Cap2.92B
Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in China, directly competing in the pharmaceutical innovation and distribution sector.
HUTCHMED (China) Limited
HCM
Mkt Cap2.2B
Hutchison China MediTech Limited engages in the research, development, and commercialization of therapies in oncology and autoimmune diseases, competing for market share in China's pharmaceutical sector.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the healthcare and pharmaceutical market in China.
Can-Fite Biopharma
CANF
Mkt Cap7.13M
Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform aimed at addressing cancer, liver, and inflammatory diseases, competing in the pharmaceutical market.
Novartis
NVS
Mkt Cap301.95B
Novartis AG, a multinational pharmaceutical company, offers a broad range of healthcare products that compete in the Chinese market, including innovative medicines and generics.
Pfizer
PFE
Mkt Cap159.99B
Pfizer Inc., a global biopharmaceutical company, competes in China through its wide range of healthcare products, including vaccines, oncology, and internal medicine.

About

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Show more...
CEO
Feng Zhou
Employees
56
Country
Virgin Islands (British)
ISIN
VGG2161P1734
WKN
000A41Z97

Listings

F
DE
2RY2.F
MU
DE
2RY1.MU
STU
DE
2RY1.STU
BOATS
BOATS
SXTC.BOATS

0 Comments

Share your thoughts

FAQ

What is China SXT Pharmaceuticals stock price today?▼
The current price of SXTC is $3.00 USD — it has decreased by -13.29% in the past 24 hours. Watch China SXT Pharmaceuticals stock price performance more closely on the chart.
What is China SXT Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange China SXT Pharmaceuticals stocks are traded under the ticker SXTC.
Is China SXT Pharmaceuticals stock price growing?▼
SXTC stock has fallen by -26.83% compared to the previous week, the month change is a +4,009.59% rise, over the last year China SXT Pharmaceuticals has showed a -98.63% decrease.
What is China SXT Pharmaceuticals market cap?▼
Today China SXT Pharmaceuticals has the market capitalization of 1.6M
What were China SXT Pharmaceuticals earnings last quarter?▼
SXTC earnings for the last quarter are -2.03 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is China SXT Pharmaceuticals revenue for the last year?▼
China SXT Pharmaceuticals revenue for the last year amounts to 1.14M USD.
What is China SXT Pharmaceuticals net income for the last year?▼
SXTC net income for the last year is -6.21M USD.
How many employees does China SXT Pharmaceuticals have?▼
As of August 30, 2026, the company has 56 employees.
In which sector is China SXT Pharmaceuticals located?▼
China SXT Pharmaceuticals operates in the Health & Wellness sector.
When did China SXT Pharmaceuticals complete a stock split?▼
The last stock split for China SXT Pharmaceuticals was on February 03, 2026 with a ratio of 1:150.
Where is China SXT Pharmaceuticals headquartered?▼
China SXT Pharmaceuticals is headquartered in Taizhou, Virgin Islands (British).